Report Detail
Global Prostacyclin Market Growth 2019-2024
- RnM3072230 |
- 07 March, 2019 |
- Global |
- 137 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
And in our report of prostacyclin, the “prostacyclin” means the drugs used for the treatment of pulmonary arterial hypertension.
Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator.
The global average price of Prostacyclin is in the decreasing trend, from 60.2 USD/Unit in 2013 to 48.4 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.
Prostacyclin is widely used for injection, for oral and for inhalation. The most proportion of Prostacyclin is used for oral, and the proportion in 2017 is about 55%. The trend of prostacyclin used for oral is increasing in the following years.
According to this study, over the next five years the Prostacyclin market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 2420 million by 2024, from US$ 1760 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prostacyclin business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostacyclin market by product type, application, key manufacturers and key regions and countries.
This study considers the Prostacyclin value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Epoprostenol Sodium
Treprostinil
Iloprost
Beraprost Sodium
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
For Injection
For Oral
For Inhalation
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
United Therapeutics
Actelion (J & J)
GSK
Teva
Toray
Tide Pharma
Bayer AG
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Prostacyclin consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Prostacyclin market by identifying its various subsegments.
Focuses on the key global Prostacyclin manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostacyclin with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Prostacyclin submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Prostacyclin Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Prostacyclin Consumption 2014-2024
- 2.1.2 Prostacyclin Consumption CAGR by Region
- 2.2 Prostacyclin Segment by Type
- 2.2.1 Epoprostenol Sodium
- 2.2.2 Treprostinil
- 2.2.3 Iloprost
- 2.2.4 Beraprost Sodium
- 2.3 Prostacyclin Consumption by Type
- 2.3.1 Global Prostacyclin Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Prostacyclin Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Prostacyclin Sale Price by Type (2014-2019)
- 2.4 Prostacyclin Segment by Application
- 2.4.1 For Injection
- 2.4.2 For Oral
- 2.4.3 For Inhalation
- 2.5 Prostacyclin Consumption by Application
- 2.5.1 Global Prostacyclin Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Prostacyclin Value and Market Share by Application (2014-2019)
- 2.5.3 Global Prostacyclin Sale Price by Application (2014-2019)
3 Global Prostacyclin by Players
- 3.1 Global Prostacyclin Sales Market Share by Players
- 3.1.1 Global Prostacyclin Sales by Players (2017-2019)
- 3.1.2 Global Prostacyclin Sales Market Share by Players (2017-2019)
- 3.2 Global Prostacyclin Revenue Market Share by Players
- 3.2.1 Global Prostacyclin Revenue by Players (2017-2019)
- 3.2.2 Global Prostacyclin Revenue Market Share by Players (2017-2019)
- 3.3 Global Prostacyclin Sale Price by Players
- 3.4 Global Prostacyclin Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Prostacyclin Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Prostacyclin Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Prostacyclin by Regions
- 4.1 Prostacyclin by Regions
- 4.1.1 Global Prostacyclin Consumption by Regions
- 4.1.2 Global Prostacyclin Value by Regions
- 4.2 Americas Prostacyclin Consumption Growth
- 4.3 APAC Prostacyclin Consumption Growth
- 4.4 Europe Prostacyclin Consumption Growth
- 4.5 Middle East & Africa Prostacyclin Consumption Growth
5 Americas
- 5.1 Americas Prostacyclin Consumption by Countries
- 5.1.1 Americas Prostacyclin Consumption by Countries (2014-2019)
- 5.1.2 Americas Prostacyclin Value by Countries (2014-2019)
- 5.2 Americas Prostacyclin Consumption by Type
- 5.3 Americas Prostacyclin Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Prostacyclin Consumption by Countries
- 6.1.1 APAC Prostacyclin Consumption by Countries (2014-2019)
- 6.1.2 APAC Prostacyclin Value by Countries (2014-2019)
- 6.2 APAC Prostacyclin Consumption by Type
- 6.3 APAC Prostacyclin Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Prostacyclin by Countries
- 7.1.1 Europe Prostacyclin Consumption by Countries (2014-2019)
- 7.1.2 Europe Prostacyclin Value by Countries (2014-2019)
- 7.2 Europe Prostacyclin Consumption by Type
- 7.3 Europe Prostacyclin Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Prostacyclin by Countries
- 8.1.1 Middle East & Africa Prostacyclin Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Prostacyclin Value by Countries (2014-2019)
- 8.2 Middle East & Africa Prostacyclin Consumption by Type
- 8.3 Middle East & Africa Prostacyclin Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Prostacyclin Distributors
- 10.3 Prostacyclin Customer
11 Global Prostacyclin Market Forecast
- 11.1 Global Prostacyclin Consumption Forecast (2019-2024)
- 11.2 Global Prostacyclin Forecast by Regions
- 11.2.1 Global Prostacyclin Forecast by Regions (2019-2024)
- 11.2.2 Global Prostacyclin Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Prostacyclin Forecast by Type
- 11.8 Global Prostacyclin Forecast by Application
12 Key Players Analysis
- 12.1 United Therapeutics
- 12.1.1 Company Details
- 12.1.2 Prostacyclin Product Offered
- 12.1.3 United Therapeutics Prostacyclin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 United Therapeutics News
- 12.2 Actelion (J & J)
- 12.2.1 Company Details
- 12.2.2 Prostacyclin Product Offered
- 12.2.3 Actelion (J & J) Prostacyclin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Actelion (J & J) News
- 12.3 GSK
- 12.3.1 Company Details
- 12.3.2 Prostacyclin Product Offered
- 12.3.3 GSK Prostacyclin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 GSK News
- 12.4 Teva
- 12.4.1 Company Details
- 12.4.2 Prostacyclin Product Offered
- 12.4.3 Teva Prostacyclin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Teva News
- 12.5 Toray
- 12.5.1 Company Details
- 12.5.2 Prostacyclin Product Offered
- 12.5.3 Toray Prostacyclin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Toray News
- 12.6 Tide Pharma
- 12.6.1 Company Details
- 12.6.2 Prostacyclin Product Offered
- 12.6.3 Tide Pharma Prostacyclin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Tide Pharma News
- 12.7 Bayer AG
- 12.7.1 Company Details
- 12.7.2 Prostacyclin Product Offered
- 12.7.3 Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Bayer AG News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Prostacyclin. Industry analysis & Market Report on Prostacyclin is a syndicated market report, published as Global Prostacyclin Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Prostacyclin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
